Table 2.

Differentially expressed proteins between patients with neoadjuvant therapy and no preoperative treatment.

Accession	Gene	Log2.Fold Change	p-Value
			Treatment	Age of Diagnosis	Gender	Disease Stage
P00747	PLG *	−3.0721709	0.033233	0.083008	0.511929	0.576933
P02679	FGG *	−2.3908585	0.014045	0.269768	0.979767	0.189957
P01024	C3 *	−1.389545	0.048588	0.328285	0.96424	0.195198
P01009	SERPINA1 *	−1.2769647	0.027569	0.970118	0.84077	0.07742
P84103	SRSF3 *	0.779147	0.049004	0.119298	0.649564	0.653696
P69891	HBG1	−1.7589103	0.02118	0.352096	0.215719	0.071367
P69892	HBG2	−1.7018783	0.031238	0.445556	0.295623	0.100417
Q9P1F3	ABRACL	1.5688169	0.031732	0.631799	0.154456	0.077132
P30085	CMPK1	0.64424732	0.011524	0.131597	0.546014	0.062366

* These proteins previously associated to survival in patients with melanoma [64].